Press Releases

Press Releases

UPLIFT, a single-arm registrational trial of UpRi in platinum-resistant ovarian cancer, expected to complete enrollment in Q3 2022 UP-NEXT, a Phase 3 trial of UpRi monotherapy maintenance in platinum-sensitive ovarian cancer, expected to initiate in Q2 2022 Interim data from UPGRADE dose escalation
January 7, 2022
Displaying 21 - 22 of 22